Cureus · 2025
Impact of Prolonged Catheterization for Vesicourethral Leakage on Continence and Quality of Life After Robotic Prostatectomy.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Taniguchi Hisanori, Ikeda Junichi, Inoue Monta, Masuo Yuki, Kinoshita Hidefumi
Аннотация
INTRODUCTION: To determine whether prolonged urinary catheterization due to vesicourethral anastomotic leakage (VAL) after robot-assisted radical prostatectomy (RARP) impacts urinary continence recovery and quality of life (QOL).
METHODS: We retrospectively analyzed 360 patients who underwent transperitoneal RARP at a single institution from January 2022 to December 2024. All patients underwent cystography on postoperative day 6 or 7. Those with VAL requiring extended catheterization were compared with patients undergoing standard removal. Continence was assessed using Question 5 of the Expanded Prostate Cancer Index Composite (EPIC), and QOL was measured with the Functional Assessment of Cancer Therapy-General (FACT-G), FACT-Prostate (FACT-P), and the EPIC urinary subscale. Outcomes were evaluated up to 24 months postoperatively.
RESULTS: VAL was detected in 36 patients (10.0%). Continence recovery did not differ significantly between the prolonged and standard catheter groups at 1, 6, or 12 months (63%, 89%, 92% vs. 54%, 85%, 93%, respectively). QOL outcomes were also comparable, although preoperative EPIC scores were lower in the prolonged catheter group. Multivariate analysis identified greater prostate specimen weight (p = 0.049) and intraoperative leakage (p = 0.002) as independent predictors of prolonged catheterization.
CONCLUSIONS: Prolonged urinary catheterization due to VAL after RARP does not adversely affect long-term urinary continence recovery or urinary-related QOL.
METHODS: We retrospectively analyzed 360 patients who underwent transperitoneal RARP at a single institution from January 2022 to December 2024. All patients underwent cystography on postoperative day 6 or 7. Those with VAL requiring extended catheterization were compared with patients undergoing standard removal. Continence was assessed using Question 5 of the Expanded Prostate Cancer Index Composite (EPIC), and QOL was measured with the Functional Assessment of Cancer Therapy-General (FACT-G), FACT-Prostate (FACT-P), and the EPIC urinary subscale. Outcomes were evaluated up to 24 months postoperatively.
RESULTS: VAL was detected in 36 patients (10.0%). Continence recovery did not differ significantly between the prolonged and standard catheter groups at 1, 6, or 12 months (63%, 89%, 92% vs. 54%, 85%, 93%, respectively). QOL outcomes were also comparable, although preoperative EPIC scores were lower in the prolonged catheter group. Multivariate analysis identified greater prostate specimen weight (p = 0.049) and intraoperative leakage (p = 0.002) as independent predictors of prolonged catheterization.
CONCLUSIONS: Prolonged urinary catheterization due to VAL after RARP does not adversely affect long-term urinary continence recovery or urinary-related QOL.